The OTA's Executive consists of the Chief Executive Officer, the National Medical Director and the Chief Financial Officer.
Chief Executive Officer (a/g)
Ms Felicity McNeill PSM
Felicity joined the Australian public service in 1997 and during that time has been a leader and instigator of reforms and service improvement. Her first twelve years were spent at the Department of Finance working in a variety of roles relating to the federal budget, procurement and contracting, assets management and financial policy. This included introducing the Gateway Review Process into the Australian Government financial framework in 2007 to improve on time and on budget delivery of Commonwealth projects and programs.
Following her time at Finance, Felicity moved to the Department of Infrastructure where she had oversight of the Australian Government’s Nation Building Roads projects in Queensland, Northern Territory, South Australia and Western Australia. In 2010 Ms McNeill joined the Australian Government Department of Health where she spent almost five years as First Assistant Secretary of the Pharmaceutical Benefits Division and six months as the head of the Office of Health Protection. During her time working on Pharmaceutical Benefits she achieved efficiencies of around $20 billion whilst also facilitating the listing of some very high cost medicines for diseases such as cystic fibrosis, diabetes, HIV, pompe and rare forms of cancer which without subsidy would cost patients in excess of $300,000 a year. It is this work that saw Ms McNeill awarded a Public Service Medal on Australia Day 2016 in recognition of ‘outstanding public service in modernising and reforming the Pharmaceutical Benefits Scheme’.
Ms McNeill is a graduate of the University of Melbourne, with an honours degree in politics and public policy.
National Medical Director
Dr Helen Opdam
Dr Helen Opdam commenced as the National Medical Director of the Organ and Tissue Authority on 1 July 2014. She is a Senior Intensive Care Specialist at the Austin Hospital in Melbourne and Director of Warringal Private Hospital Intensive Care Unit. Her intensive care interests include improving patient care through enhancing hospital systems and neuro-intensive care.
Dr Opdam has a long standing commitment to organ and tissue donation, holding the position of the inaugural State Medical Director of DonateLife Victoria from 2009 to June 2015. In 1998 in Victoria Dr Opdam led the implementation of the routine review of hospital deaths with the aim of optimising identification of potential donors and ensuring the option for donation is discussed with patients' families. In 2002 she was appointed as a medical consultant to the Victorian Organ Donation Agency, providing medical suitability and other clinical advice on donation cases. She was on the National Institute of Clinical Studies (NICS) Advisory Committee that oversaw the National Organ Donation Collaborative (2006-2009).
Dr Opdam is a member of the Australian and New Zealand Intensive Care Society (ANZICS) Death and Organ Donation Working Party that has developed the ANZICS Statement on Death and Organ Donation. She regularly facilitates Medical ADAPT workshops to provide education to Intensive Care Specialists and trainees and other doctors on brain death and organ donation.
Dr Opdam is the Chair of the OTA Data and Audit Working Group, which oversees the national audit of deaths to detect potential organ donors. She contributes to numerous other committees and workings groups including being a Council member of the International Society for Organ Donation and Procurement, and on the NHMRC Expert Advisory Group for the development of ethical guidelines on the eligibility criteria and allocation protocols for organ transplantation from deceased donors. She is a regular invited speaker at national and international conferences.
Dr Opdam graduated from Monash University in 1990 with First Class Honours.
Chief Financial Officer
Ms Judy Harrison
Ms Judy Harrison has been Chief Financial Officer of the OTA since March 2010. She provides assurance on the OTA's financial sustainability, its control framework, and the accuracy of its appropriation bills, budget estimates and financial reporting. The Chief Financial Officer is the principal financial advisor to the OTA's CEO and executive team.
Ms Harrison was the Director of Financial Reporting and Treasury within the Department of Health, a role she held for five years. This role encompassed managing the department's treasury team and responsibility for both monthly and annual external reporting requirements.
Ms Harrison is a qualified accountant with significant previous financial reporting and financial management experience in both the public and private sectors, including five years consulting, five years in the United Kingdom banking sector, and audit experience gained in a major chartered accounting firm.